AliveX Biotech Achieves Perfect Score in CAP Proficiency Testing 2024 and Files IPO Prospectus
AliveX Biotech
Precision Medicine Solution Provider
Recently, the College of American Pathologists (CAP) announced the proficiency testing results for some projects in 2024.AliveX Biotech Achieves Perfect Score in 2024 CAP Proficiency Testing (PT) Program
Since its establishment, AliveX Biotech has always been committed to providing precise and reliable testing services for top-tier research institutions and medical organizations both in China and abroad, relying on strict quality control processes, sophisticated experimental techniques, and powerful multi-omics data analysis capabilities. Passing the CAP 2024 PT program once again demonstrates AliveX Biotech's consistent technical strength and excellent quality management system.
AliveX Biotech will take this achievement as a new starting point, continue to deepen its expertise in multi-omics testing technologies and international services, support scientific research and the development of precision medicine, set higher standards for the industry, and create more possibilities.
About CAP
The College of American Pathologists (CAP) is the world’s leading accreditation organization for medical laboratory quality. Through CAP Proficiency Testing (PT), it conducts authoritative assessments of laboratories’ testing accuracy and quality management capabilities. CAP-PT covers multiple testing areas, ensuring the reliability and consistency of laboratory test results through rigorous standards and scientific methods, and is internationally recognized as a symbol of laboratory competency certification.
About AliveX Biotech
AliveX Biotech is a leading AI + multi-omics technology platform company in China, possessing an end-to-end dry and wet lab closed-loop multi-omics experimental platform as well as an AI biological computing platform. This includes high-quality bioanalytical technologies such as spatiotemporal single-cell omics, targeted proteomics, metabolomics/lipidomics, along with computational technologies like multi-omics integrative analysis, AI modeling, knowledge graphs, and disease pharmacological mechanism modeling to efficiently empower research and development. AliveX Biotech has an internationally renowned interdisciplinary team of academician professors and industry experts, providing customized scientific research solutions for research institutions and pharmaceutical partners. These solutions include studies on disease and drug mechanisms, discovery and evaluation of biomarkers and targets, patient stratification, multimodal AI prediction, optimization of clinical trial protocols, and precision medicine strategies. AliveX Biotech has served over a hundred clinical and research institutions and international large pharmaceutical companies. The company owns dozens of core technology independent intellectual property rights and has obtained National High-tech Enterprise Certification, CAP certification from the American Pathology Society, and ISO9001 certification.
